In CD, TGF-β is suggested to serve as a growth factor, promoting parasite replication (40), and treatment with a TGF-β receptor inhibitor decreased the parasitemia, heart damage, and mortality in infected mice (41). The gene discussed is TGFB1; the disease is parasitic infectious disease.